Infectious Diseases
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
March 18, 2019
March 18, 2019
March 11, 2019
February 28, 2019
February 25, 2019
February 22, 2019
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community